Delivery Order SPE2DB24D2101-SPE2DB24FKFSD

Award Date 8/6/24
Potential Completion Date 8/27/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,352.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,306.27, is a Firm Fixed Price Delivery Order for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a completion date of November 26, 2024 and was awarded on November 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ERLEADA 60 MG TABLET UU 120S. The $20,925.06 firm fixed price delivery order has a completion date of May 5, 2022. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of ERLEADA 60 MG TABLET UU 120S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $17,419.28 and a performance period through March 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract award, valued at $7,558.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product ERLEADA 60 MG TABLET UU 120S. It has an ultimate completion date of March 27, 2025 and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug...
This federal contract award is for the delivery of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $7,306.27 and is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025....
This federal contract award, valued at $73,062.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of ERLEADA 60 MG TABLET UU 120S. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a prescription medication, to support military healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,676.34 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET UU 120S, a medication used for medical treatment. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFSD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of ERLEADA 60 MG TABLET UU 120S. The award, valued at $7,306.27, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation, and Amerisourcebergen is the prime contractor. The award has an ultimate completion date of August 27, 2024.

Generated 11/5/24, 9:25 AM